Visual aids

BEHAVIORAL2 trials

Sponsors

Abramson Cancer Center at Penn Medicine, Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Conditions

Anti-Glaucoma MedicationsCandidates for BRCA 1/2 Genetic Testing

Unknown Phase

A Study of the Communication of Genetic Test Results By Telephone: A Multi-Center Study

CompletedNCT01736345

Abramson Cancer Center at Penn MedicineCandidates for BRCA 1/2 Genetic Testing

Start: 2012-12-03End: 2015-11-30Updated: 2022-07-27

Preoperative Visual Aids on Glaucoma Surgical Patients

CompletedNCT06478095

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong KongAnti-Glaucoma Medications

Start: 2023-03-08End: 2024-03-28Updated: 2024-06-28

Related Papers

Preferences for in‐person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study

Clinical Genetics2018-11-1227 citations

Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone Study

JCO Precision Oncology2018-11-0114 citations

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.

2018-09-0140 citations

Extended follow-up in the COGENT study: A randomized study of in-person versus telephone disclosure of cancer genetic test results.

Journal of Clinical Oncology2017-05-20

Knowledge outcomes in a randomized trial of telephone vs. in-person disclosure of genetic testing: The COGENT study.

Journal of Clinical Oncology2017-05-20

Patient-reported outcomes in a multicenter randomized study of in-person versus telephone disclosure of genetic test results for cancer susceptibility.

Journal of Clinical Oncology2016-05-202 citations